Expert Perspectives

Ramucirumab for Metastatic Non-Small Cell Lung Cancer

Cancer Therapy Advisor spoke with Ronald J. Scheff, MD. READ MORE »

Emerging Treatments in Ovarian Cancer

Experts discuss the use of antiangiogenic agents, PARP inhibitors, folate receptor alpha-targeting therapies, and neoantigen vaccines to treat ovarian cancer. READ MORE »

New Directions in Newly Diagnosed Multiple Myeloma

Choice of therapy for multiple myeloma should be guided by specific patients’ comorbidities and toxicity profiles. Cancer Therapy Advisor reached out to 3 experts in this specialty to talk about therapies to watch in the setting of newly diagnosed disease. READ MORE »

MET Inhibition in Non-Small Cell Lung Cancer

Cancer Therapy Advisor spoke with D. Ross Camidge, MD, PhD, to get his thoughts on promising new options for the treatment of NSCLC. READ MORE »

Treating Patients With Germline BRCA-Mutated, Her2-Negative Metastatic Breast Cancer

Cancer Therapy Advisor asked 3 doctors their thoughts on the use of PARP inhibitors in the adjuvant setting in BRCA-mutated, HER2-negative disease. READ MORE »

Management Issues in Metastatic Prostate Cancer

Amar U. Kishan, MD, and Jad Chahoud, MD, MPH, discuss their strategies for managing metastatic castration-sensitive prostate cancer. READ MORE »

New Directions in Drug Development: Multiple Myeloma

Read these expert opinions on the future of BCMA-directed chimeric antigen receptor CAR-T therapies and encouraging new targets in multiple myeloma. READ MORE »

Chronic Lymphocytic Leukemia: New Treatment Approaches Highlighted at ASCO 2019

Cancer Therapy Advisor asked 3 experts in chronic lymphocytic leukemia to weigh in on minimal residual disease measurement, CAR-T therapies, genomic testing, and key data that were presented at the 2019 ASCO Annual Meeting. READ MORE »

Translating ASCO Data Into Clinical Practice for Patients with Lymphoma

What is your strategy for communicating with patients about the general efficacy of drugs that exist to treat classical Hodgkin lymphoma? READ MORE »

Using Novel Anti-Androgens in Non-Metastatic CRPC

What should be the basis for starting non-metastatic CRPC patients on one of the novel anti-androgens? READ MORE »

Clinical Insights in Metastatic Breast Cancer

Cancer Therapy Advisor asked 3 experts to weigh in on the treatment of metastatic breast cancer. READ MORE »

Treating Patients with Nonsquamous Non-Small Cell Lung Cancer

Cancer Therapy Advisor asked 2 experts to weigh in on recommended treatment modalities. READ MORE »

Clinical Insights in Soft Tissue Sarcoma

Cancer Therapy Advisor asked 2 experts to weigh in on clinical insights in soft tissue sarcoma. READ MORE »

Translating ASCO Data Into Clinical Practice for Patients with Breast Cancer

Cancer Therapy Advisor asked 3 experts to weigh in on translating ASCO data into clinical practice for patients with breast cancer. READ MORE »

Decisions in the Clinic: Treating Patients With Hepatocellular Carcinoma

Cancer Therapy Advisor spoke with three experts on their treatment option choices for hepatocellular carcinoma. READ MORE »

Decisions in the Clinic: Treating Patients With Waldenström Macroglobulinemia

Cancer Therapy Advisor asked 3 experts to weigh in on recommended treatment modalities for patients with Waldenström macroglobulinemia. READ MORE »

Decisions in the Clinic: Treating Patients With Multiple Myeloma

Cancer Therapy Advisor asked 3 experts to weigh in on recommended treatment modalities for patients with multiple myeloma. READ MORE »

Decisions in the Clinic: Treating Patients With Chronic Myeloid Leukemia